Examining Cutaneous Disease Activity as an Outcome Measure for Clinical Trials in Dermatomyositis

    Rebecca G. Gaffney, Rui Feng, David R. Pearson, M. Tarazi, Victoria P. Werth
    Image
    Studysummary This study suggests that for dermatomyositis patients with minimal skin disease activity, further improvement in cutaneous symptoms may not translate into better quality of life, highlighting a need to revise trial endpoints.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →